WTFG
MRNA icon

Wood Tarver Financial Group’s Moderna MRNA Stock Holding History

Wood Tarver Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed – – 449
2025
Q2 		$0 Hold
1
– – ﹤0.01% 656
2025
Q1 		$29 Hold
1
– – ﹤0.01% 701
2024
Q4 		$0 Buy
+1
New +$48 ﹤0.01% 712

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wood Tarver Financial Group's MRNA Position: Q3 2025 in Review

Wood Tarver Financial Group sold out of Moderna (MRNA) in Q3 2025, closing a stake of 1 share.

Wood Tarver Financial Group first reported a position in MRNA in Q4 2024 and held it in 3 quarters. The position peaked at $29 in Q1 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Wood Tarver Financial Group reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Wood Tarver Financial Group sold 1 Moderna share in Q3 2025.
  • Wood Tarver Financial Group first reported a position in Moderna in Q4 2024 and held it in 3 quarters.
  • Wood Tarver Financial Group's Moderna position peaked at $29 in Q1 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Wood Tarver Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.